杜嘉祺回巢出任主席 友邦(01299.HK)現升逾3%
友邦保險(01299.HK)公布,獨立非執行主席及獨立非執行董事謝仕榮通知董事會將退任,自今年9月30日起生效,公司並已委任杜嘉祺接替,待監管批准後,將於今年10月1日起生效。杜嘉祺曾於2010年至2017年間擔任友邦保險集團首席執行官兼總裁,他將於今年9月30日完成匯控(00005.HK)非執行主席的任期。
友邦今早高開1.42%,最高見69元。現報68.9元,升3.07%,成交1,150.79萬股,涉資7.86億元。(gc/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.